InvestorsHub Logo
Followers 51
Posts 9143
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 01/18/2023 12:53:09 AM

Wednesday, January 18, 2023 12:53:09 AM

Post# of 13522
Moderna intends to submit for regulatory approval in the first half of 2023. The trial is ongoing, and additional efficacy analyses are planned as cases accrue, including for severe RSV..........
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News